Tag Archives: Biologics by McKesson

Biologics by McKesson Selected to Provide VONJO and PYRUKYND

Biologics by McKesson continues to solidify its leadership position a provider for limited and exclusive drugs in the specialty pharmacy market

Biologics Selected by Agios Pharmaceuticals as Exclusive Distributor of PYRUKYND®

PYRUKYND prescriptions are processed exclusively through Biologics by McKesson to give patients a seamless experience

Biologics by McKesson Starting the New Year With Momentum

Biologics by McKesson, selected as a specialty pharmacy distributor for three specialty drugs recently, is starting the new year with momentum

Biologics by McKesson Selected to Provide TRUSELTIQ and LUMAKRAS

Biologics specialty pharmacy teams includes pharmacists with in-depth knowledge of therapies, experienced nurses, and financial counselors who are familiar with various financial assistance programs and organizations that help patients

Biologics by McKesson Expands Oncology Practices Offerings

Biologics has contracted with more than 500 payers and offers more than 150 therapies

AVEO Oncology’s Limited Specialty Pharmacy Distribution Network for Fotivda Selected

Biologics by McKesson and Onco360 continue to solidify their positions as market-leading specialty pharmacy providers of oncology drugs

BluePrint’s AYVAKIT and GAVRETO™ Selected Biologics and PantherRx Rare as Limited Specialty Pharmacies

Blueprint creates medicines that selectively target genetic drivers, with the goal of staying one step ahead across stages of disease

Biologics by McKesson and AllianceRx Expand Specialty Pharmacy Oncology Offerings

INQOVI is for the treatment of adults with intermediate and high-risk myelodysplastic syndromes (MDS) including chronic myelomonocytic leukemia (CMML), two blood malignancies